Total Payments
$27,589
2024 Payments
$3,006
Companies
49
Transactions
1,033
Medicare Patients
13,850
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$24,217 (87.8%)
Consulting$2,600 (9.4%)
Travel$460.70 (1.7%)
Education$311.67 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,217 | 1,024 | 87.8% |
| Consulting Fee | $2,600 | 1 | 9.4% |
| Travel and Lodging | $460.70 | 2 | 1.7% |
| Education | $311.67 | 6 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $8,525 | 255 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,407 | 184 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $3,030 | 133 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,036 | 35 | $0 (2024) |
| INOGEN, INC. | $653.67 | 36 | $0 (2024) |
| Mylan Specialty L.P. | $591.09 | 27 | $0 (2024) |
| Insmed, Inc. | $584.47 | 26 | $0 (2024) |
| Philips Electronics North America Corporation | $551.73 | 31 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $534.61 | 18 | $0 (2020) |
| Genentech USA, Inc. | $515.37 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,006 | 109 | AstraZeneca Pharmaceuticals LP ($867.95) |
| 2023 | $4,067 | 144 | GlaxoSmithKline, LLC. ($985.81) |
| 2022 | $3,058 | 134 | AstraZeneca Pharmaceuticals LP ($846.61) |
| 2021 | $3,207 | 137 | AstraZeneca Pharmaceuticals LP ($910.00) |
| 2020 | $2,448 | 117 | GlaxoSmithKline, LLC. ($857.28) |
| 2019 | $6,571 | 156 | GlaxoSmithKline, LLC. ($4,191) |
| 2018 | $2,188 | 117 | GlaxoSmithKline, LLC. ($539.12) |
| 2017 | $3,046 | 119 | AstraZeneca Pharmaceuticals LP ($685.42) |
All Payment Transactions
1,033 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $32.30 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Airway Clearance Device | ||||||
| 11/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $30.84 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/11/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $33.58 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Respiratory | ||||||
| 09/28/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: Respiratory | ||||||
| 09/20/2024 | INOGEN, INC. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 09/18/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $89.99 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,803 | 6,117 | $956,840 | $437,400 |
| 2022 | 26 | 3,561 | 6,020 | $961,918 | $428,217 |
| 2021 | 22 | 3,332 | 5,669 | $901,895 | $419,993 |
| 2020 | 25 | 3,154 | 5,151 | $764,173 | $331,611 |
Total Patients
13,850
Total Services
22,957
Medicare Billing
$1.6M
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 846 | 1,667 | $283,390 | $168,294 | 59.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 317 | 1,214 | $182,100 | $80,287 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 578 | 844 | $101,280 | $59,103 | 58.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 376 | 376 | $112,800 | $48,459 | 43.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 269 | 300 | $90,000 | $32,360 | 36.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 266 | 345 | $31,050 | $9,063 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $18,250 | $6,502 | 35.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 18 | 108 | $16,200 | $4,210 | 26.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 33 | 33 | $14,190 | $3,177 | 22.4% |
| 31622 | Diagnostic exam of lung airway using an endoscope | Facility | 2023 | 27 | 28 | $10,080 | $3,101 | 30.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 28 | 28 | $13,160 | $2,730 | 20.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 62 | $12,400 | $2,378 | 19.2% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 223 | 228 | $6,840 | $2,195 | 32.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 17 | 64 | $8,320 | $2,086 | 25.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 233 | 238 | $9,520 | $1,974 | 20.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $3,120 | $1,928 | 61.8% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 48 | 48 | $14,400 | $1,655 | 11.5% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 223 | 228 | $6,840 | $1,642 | 24.0% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 13 | 13 | $2,600 | $1,262 | 48.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 24 | 24 | $1,710 | $1,032 | 60.3% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 24 | 24 | $1,710 | $999.28 | 58.4% |
| 32554 | Aspiration of fluid from chest cavity | Facility | 2023 | 11 | 12 | $7,200 | $898.80 | 12.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 25 | 25 | $3,116 | $743.50 | 23.9% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 35 | 35 | $2,775 | $491.05 | 17.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 37 | 39 | $2,925 | $425.49 | 14.5% |
About Fernando Keller
Fernando Keller is a Critical Care Medicine healthcare provider based in Boynton Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669596201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Fernando Keller has received a total of $27,589 in payments from pharmaceutical and medical device companies, with $3,006 received in 2024. These payments were reported across 1,033 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($24,217).
As a Medicare-enrolled provider, Keller has provided services to 13,850 Medicare beneficiaries, totaling 22,957 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Boynton Beach, FL
- Active Since 03/19/2007
- Last Updated 03/24/2023
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1669596201
Products in Payments
- TRELEGY ELLIPTA (Drug) $2,188
- NUCALA (Biological) $2,071
- OFEV (Drug) $1,564
- FASENRA (Biological) $1,401
- TEZSPIRE (Biological) $1,149
- BREZTRI (Drug) $944.36
- STIOLTO RESPIMAT (Drug) $858.56
- DUPIXENT (Biological) $833.59
- SYMBICORT (Drug) $831.55
- UPTRAVI (Drug) $639.63
- BEVESPI AEROSPHERE (Drug) $497.07
- ANORO (Drug) $486.58
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $475.11
- Arikayce (Drug) $433.02
- Prolastin-C Liquid (Biological) $367.90
- TYVASO (Drug) $337.94
- Adempas (Drug) $320.02
- STIOLTO (Drug) $308.73
- FASENRA (Drug) $298.82
- (8874) inCourage (Device) $288.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Boynton Beach
Dr. Nevine Carp, M.d, M.D
Critical Care Medicine — Payments: $10,100
Critical Care Medicine $10,100
Dr. Wambura Mkono, M.d, M.D
Critical Care Medicine — Payments: $513.11
Critical Care Medicine $513.11
Lea White
Critical Care Medicine — Payments: $221.68
Critical Care Medicine $221.68
Joshua Heatwole, Arnp, ARNP
Critical Care Medicine — Payments: $167.71
Critical Care Medicine $167.71
Ryan Speaker, Registered Nurse, REGISTERED NURSE
Critical Care Medicine
Critical Care Medicine
Maureen Mikosz, Rn, RN
Critical Care Medicine
Critical Care Medicine